Psoriasis is a serious, life-long, inflammatory, non-communicable, auto-immune disease / immune-mediated, genetic disease manifesting in the skin and/or joints, and carries severe physical, mental and socio-economic burdens on over 125 million people worldwide, including 1. Summary. Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease. Psoriasis is an immune-mediated, genetic disease manifesting in the skin or joints or both. A diverse team of clinicians with a range of expertise is often needed to treat the disease.
Nowadays, Ps is considered an immune-mediated skin disease, and PsA regarded as a seronegative (rheumatoid factor negative) arthritis. Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. Psoriasis is generally thought to be a genetic disease which is triggered by environmental factors. The underlying mechanism involves the immune system reacting to skin cells. Dermatologic manifestations of systemic illnesses such as the rash of secondary syphilis may also be confused with psoriasis. It is an immune-mediated, genetic disease manifesting in the skin and/or the joints.
Psoriasis is a complex immune-mediated disease that can manifest in the skin and joints. Psoriasis can affect the skin, nails, scalp, and joints to different degrees in each patient. Family studies have shown a genetic predisposition for the disease, with the literature illustrating certain susceptibility alleles in immune-related genes. Glossary of skin conditions our treatments can help remove or diminish. Psoriasis is an immune-mediated disease with genetic predisposition, but no distinct immunogen has been identified. Treatment goals include improvement of skin, nail, and joint lesions plus enhanced quality of life.
Psoriasis And Cardiovascular Risk: Immune-mediated Crosstalk Between Metabolic, Vascular And Autoimmune Inflammation